IMUTEX

Updated 188 days ago
Private Limited Company
  • Active - 10124988 (CH)
  • Age: 7 years
  • ID: 30286861/97
The Walbrook Building, 25 Walbrook, London EC4N 8AF
CLICK HERE TO SEE DETAILS OF COMPANY CHANGES
• 72110 - Research and experimental development on biotechnology
Imutex is collaborating with the National Institute of Allergy and Infectious Diseases (NIAID) to accelerate development of both vaccines... Imutex is leveraging technology licensed from PepTcell to develop a Broad-Spectrum ‘Universal' Influenza Vaccine (BIV), called FLU-v, against multiple flu strains... Vaccine programmes. A joint venture between PepTcell and hVIVO, Imutex is developing vaccines against influenza and mosquito borne diseases. Find out more!
Also known as: IMUTEX LIMITED, Imutex Ltd, IMUTEX Sciences
Registration numbers: 02326557 (W), 10124988 (CH)
Primary location: London United Kingdom
  • 0
  • 0
Interest Score
2
HIT Score
0.56
Chairman
Cathal Friel

UK Company Data

Company number
10124988		 Account category
TOTAL EXEMPTION FULL		 Account ref. day
31		 Account ref. month
12
Accounts next due date
2024-09-30		 Accounts last made up date
2022-12-31		 Returns next due date
2017-05-12		 Returns last made up date
N/A
Num. mort. charges
0		 Num. mort. outstanding
0		 Num. mort. part. satisfied
0		 Num. mort. satisfied
0
Num. gen. partners
0		 Num. lim. partners
0
Domain
imutex.com
Actual
imutex.com
IP
35.242.178.204
Status
OK
Category
Company
0 comments Add a comment